A detailed history of Marshall Wace, LLP transactions in Becton Dickinson & CO stock. As of the latest transaction made, Marshall Wace, LLP holds 669,572 shares of BDX stock, worth $156 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
669,572
Previous 11,093 5935.99%
Holding current value
$156 Million
Previous $2.7 Million 6027.4%
% of portfolio
0.26%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $154 Million - $163 Million
658,479 Added 5935.99%
669,572 $166 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $44.6 Million - $51.4 Million
-192,171 Reduced 94.54%
11,093 $2.7 Million
Q3 2023

Nov 14, 2023

SELL
$254.9 - $283.59 $253 Million - $282 Million
-992,797 Reduced 83.01%
203,264 $52.5 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $132 Million - $147 Million
555,090 Added 86.6%
1,196,061 $316 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $75.2 Million - $84.9 Million
327,232 Added 104.3%
640,971 $159 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $68.5 Million - $80.6 Million
313,739 New
313,739 $79.8 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $1.24 Million - $1.45 Million
-5,269 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$243.64 - $270.48 $2.2 Million - $2.44 Million
-9,010 Reduced 63.1%
5,269 $1.4 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $3.29 Million - $3.58 Million
14,279 New
14,279 $3.59 Million
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $263,127 - $287,929
-1,131 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $16 Million - $17.7 Million
-68,821 Reduced 98.38%
1,131 $275,000
Q4 2020

Feb 16, 2021

BUY
$221.92 - $245.94 $1.98 Million - $2.2 Million
8,933 Added 14.64%
69,952 $17.5 Million
Q3 2020

Nov 16, 2020

BUY
$215.77 - $276.76 $13.2 Million - $16.9 Million
61,019 New
61,019 $14.2 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $3.36 Million - $4.02 Million
-15,259 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $2.43 Million - $3.46 Million
-12,396 Reduced 44.82%
15,259 $3.51 Million
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $6.5 Million - $7.34 Million
-27,496 Reduced 49.86%
27,655 $7.52 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $8.94 Million - $9.93 Million
38,782 Added 236.92%
55,151 $14 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $3.12 Million - $3.54 Million
14,369 Added 718.45%
16,369 $4.13 Million
Q1 2019

May 14, 2019

SELL
$206.05 - $248.17 $5.53 Million - $6.66 Million
-26,847 Reduced 93.07%
2,000 $499,000
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $5.16 Million - $6.5 Million
25,194 Added 689.68%
28,847 $6.5 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $851,404 - $935,168
3,653 New
3,653 $953,000
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $7.86 Million - $9.19 Million
-38,245 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$189.0 - $222.64 $7.23 Million - $8.51 Million
38,245
38,245 $8.19 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.